Cannabis in Brazil

December 2022 | 18 pages | ID: C8EAB5E82BC3EN
Euromonitor International Ltd

Abstracts

2022 was an interesting and intense year for the cannabis market in Brazil. New products hit the market, produced by Brazilian companies that are becoming more and more complex as well as better funded, allowing for a wider range of consumers to access medical cannabis. At the same time, legal uncertainty put prescribing doctors and users in a tight spot, with CFM (Conselho Federal de Medicina)’s decision to recommend cannabis use only for the treatment of epilepsy. Although the decision lasted...

Euromonitor International's Cannabis in Brazil market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market – legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2026 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD, Medical Cannabis.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Cannabis market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

CANNABIS IN BRAZIL
EXECUTIVE SUMMARY
CANNABIS BACKGROUND
COUNTRY INSIGHT
CANNABIS LEGISLATION
Summary 1 Cannabis Legislation in Brazil
CANNABIS DISTRIBUTION
CANNABIS TAXATION
CANNABIS PRODUCTION
ILLICIT CANNABIS MARKET
MARKET INDICATORS
Table 1 Cannabis User Population by Legal vs Illicit 2019-2022
MARKET DATA
Table 2 Sales of Cannabis by Category: Value 2019-2022
Table 3 Sales of Cannabis by Category: % Value Growth 2019-2022
Table 4 Sales of Cannabis by Legal vs Illicit 2019-2022
Table 5 Distribution of Cannabis by Format: % Value 2019-2022
Table 6 Distribution of Cannabis by Format and Category: % Value 2022
Table 7 Forecast Sales of Cannabis by Category: Value 2022-2027
Table 8 Forecast Sales of Cannabis by Category: % Value Growth 2022-2027
Table 9 Forecast Sales of Cannabis by Legal vs Illicit 2022-2027
MEDICAL CANNABIS
Market Sizes
Cannabinoids
Brands
Distribution
CATEGORY DATA
Table 10 Sales of Medical Cannabis by Category: Volume 2019-2022
Table 11 Sales of Medical Cannabis by Category: Value 2019-2022
Table 12 Sales of Medical Cannabis by Category: % Volume Growth 2019-2022
Table 13 Sales of Medical Cannabis by Category: % Value Growth 2019-2022
Table 14 Sales of Medical Cannabis by CBD vs THC content: % Value 2019-2022
Table 15 Distribution of Medical Cannabis by Format: % Value 2019-2022
Table 16 Forecast Sales of Medical Cannabis by Category: Volume 2022-2027
Table 17 Forecast Sales of Medical Cannabis by Category: Value 2022-2027
Table 18 Forecast Sales of Medical Cannabis by Category: % Volume Growth 2022-2027
Table 19 Forecast Sales of Medical Cannabis by Category: % Value Growth 2022-2027
ADULT-USE CANNABIS
CBD
Table 20 Forecast Sales of CBD by Category: Volume 2022-2027
Table 21 Forecast Sales of CBD by Category: Value 2022-2027
Table 22 Forecast Sales of CBD by Category: % Volume Growth 2022-2027
Table 23 Forecast Sales of CBD by Category: % Value Growth 2022-2027